Evidence map›Paper›PMID 29578537›Full record

ArticleNature methods2018

Photoactivatable drugs for nicotinic optopharmacology.

Sambashiva Banala, Matthew C Arvin, Nicholas M Bannon, Xiao-Tao Jin, John J Macklin, Yong Wang, Can Peng, Guiqing Zhao, John J Marshall, Kyle R Gee and 8 more

Abstract read
In one paragraph

Article in Nature methods, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. A hydrophobic photouncaging reaction to profile the lipid droplet interactome in tissues.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Sambashiva BanalaJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, Virginia, USA.
Matthew C ArvinDepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.ORCID 0000-0002-1744-2142
Nicholas M BannonDepartment of Neurobiology, Weinberg School of Arts and Sciences, Northwestern University, Evanston, Illinois, USA.
Xiao-Tao JinDepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
John J MacklinJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, Virginia, USA.
Yong WangDepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Can PengDepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Guiqing ZhaoDepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
John J MarshallDepartment of Physiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Kyle R GeeMolecular Probes, Thermo Fisher, Eugene, Oregon, USA.
David L WokosinDepartment of Physiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Veronica J KimDepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
J Michael McIntoshGeorge E. Wahlen Veterans Affairs Medical Center and Departments of Psychiatry and Biology, University of Utah, Salt Lake City, Utah, USA.
Anis ContractorDepartment of Neurobiology, Weinberg School of Arts and Sciences, Northwestern University, Evanston, Illinois, USA.ORCID 0000-0002-5131-2536
Henry A LesterJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, Virginia, USA.ORCID 0000-0002-5470-5255
Yevgenia KozorovitskiyDepartment of Neurobiology, Weinberg School of Arts and Sciences, Northwestern University, Evanston, Illinois, USA.ORCID 0000-0002-3710-1484
Ryan M DrenanDepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.ORCID 0000-0002-8141-8577
Luke D LavisJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, Virginia, USA.ORCID 0000-0002-0789-6343

Funding

Venoms, Biological Resources, Molecular BiologyP01GM048677 · NIGMS · UNIVERSITY OF UTAH · PI MCINTOSH, J MICHAEL · 1993 to 2018
$32.2M
The role of glutamate receptors in compulsive and perseverative behaviorR01MH099114 · NIMH · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CONTRACTOR, ANIS · 2012 to 2022
$4.5M
Identifying nicotine withdrawal mechanisms hidden within habenular complexityR01DA040626 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ryan Michael Drenan · 2016 to 2026
$4.0M
Nicotinic acetylcholine receptor function in the mesolimbic dopamine systemR01DA035942 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI DRENAN, RYAN MICHAEL · 2014 to 2023
$3.9M
Physiology Core - Interdepartmental Two-photon Imaging CenterP30NS054850 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SURMEIER, DALTON JAMES · 2007 to 2012
$3.3M
Novel nAChR-Targeted PeptidesR01GM103801 · NIGMS · UNIVERSITY OF UTAH · PI MCINTOSH, J MICHAEL · 2012 to 2019
$2.4M
Tools for inside-out pharmacology: nicotinic agentsR01DA037161 · NIDA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI LESTER, HENRY A. · 2013 to 2016
$1.3M
Targeting convergent modulatory systems to regulate striatal synaptogenesisF32NS103243 · NINDS · NORTHWESTERN UNIVERSITY · PI BANNON, NICHOLAS · 2017 to 2018
$116k
NIDA NIH HHS R01 DA035942NIDA NIH HHS R01 DA037161NIDA NIH HHS R01 DA040626NIGMS NIH HHS P01 GM048677NIGMS NIH HHS R01 GM103801NIMH NIH HHS R01 MH099114NINDS NIH HHS F32 NS103243NINDS NIH HHS P30 NS054850
6 · The paper itself

Abstract

Photoactivatable pharmacological agents have revolutionized neuroscience, but the palette of available compounds is limited. We describe a general method for caging tertiary amines by using a stable quaternary ammonium linkage that elicits a red shift in the activation wavelength. We prepared a photoactivatable nicotine (PA-Nic), uncageable via one- or two-photon excitation, that is useful to study nicotinic acetylcholine receptors (nAChRs) in different experimental preparations and spatiotemporal scales.

Indexed as

Photochemical ProcessesAnimalsBrainCalciumImmunohistochemistryMiceMicroscopy, ConfocalNicotineReceptors, NicotinicSpectrometry, FluorescenceSpectrophotometry, UltravioletCalciumNicotineReceptors, Nicotinic

Identifiers

PMID29578537
PMCPMC5923430

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.